Objectives: To know which symptoms of rosacea can be successfully treated with lasers and light sources and which ones should be preferred
Introduction: Rosacea is a common condition in patients of Fitzpatrick’s skin type I and II
therapies have to be chosen according to the symptoms and severity. The main signs are
redness with teleangiectasia, papules and pustules, phymatous proliferation and thickening esp an the nose and ocular symptoms , mainly conjunctivitis.
Only the redness and dilated vessels and partly thepapules and inflammation can be treated with lasers, for all other symptoms topical and sxystemic medication is needed.
The Use of energy and laser/ light-based therapies has significantly increased in dermatology practice over the
Materials / method: In a double blinded, split face randomized control trial diffuse facial erythema was treated with nonpurpuragenic 595-nm PDL or microsecond 1064-nm Nd:Yag laser. Both lasers were found to be efficacious, though PDL may be more effective and Nd:yag was less painful.
In another split-face comparative study (n=15), 595-nm PDL and a pulsed 532-nm KTP laser were effective in the treatment of facial telangiectasia and redness.
Long-pulsed Nd:YAG as well as PDL are effective in rosacea-associated nasal telangiectasia, but should be used carefully to avoid side effects. Flashlamp PDL is better in term
Results: Despite numerous publications on successful treatment with vascular lasers and the reduction of inflammation after pulsed dye laser and IPL, still laser and light sources are not able to achieve a complete or permanent cure.
Conclusion: So the main indication of lasers and light sources can be seen in rosacea with significant erythema andteleangiectasia as a first and second line treatment and for patients who do not response sufficiently on classic medication as a second line treatment to improve the overall outcome.
Declaraciones
¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No
¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No
¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No
¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No
Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.